or Try an Advanced Search...

    Technical Analysis for EXAI - Exscientia Limited

    Grade Last Price % Change Price Change
    F 4.25 0.24% 0.01
    EXAI closed up 0.24 percent on Monday, April 22, 2024, on 54 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical EXAI trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.24%
    New 52 Week Low Weakness 0.24%
    Wide Bands Range Expansion 0.24%
    Oversold Stochastic Weakness 0.24%
    Wide Bands Range Expansion -2.52%
    Oversold Stochastic Weakness -2.52%
    NR7 Range Contraction -1.62%
    Narrow Range Bar Range Contraction -1.62%
    Older End-of-Day Signals for EXAI ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 21 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Up 3% about 22 hours ago
    Rose Above Previous Day's High about 22 hours ago
    Up 2% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    EXAI Chart by TradingView
    Basic chart:

    Profile

    Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Artificial Intelligence Health Sciences Clinical Trial Precision Medicine Clinical Pharmacology Systems Biology Evidence Based Medicine

    Is EXAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 21 Exscientia GAAP EPS of -$0.42 beats by $0.91, revenue of $3.1M misses by $43.5M
    Mar 21 Exscientia plc (EXAI) Q4 2023 Earnings Call Transcript
    Mar 21 Exscientia files for $300M mixed shelf offering
    Mar 21 Exscientia Business and Financial Update for the Full Year 2023
    Mar 20 Exscientia FY 2023 Earnings Preview
    Mar 19 Exscientia plc's (NASDAQ:EXAI) market cap touched US$797m last week, benefiting both individual investors who own 48% as well as institutions
    Mar 14 Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
    Mar 4 The Top 3 Healthcare Stocks to Buy on Weakness in 2024
    Mar 4 Anagenex expands leadership team with appointment of Adrian Schreyer as CTO
    Feb 28 Exscientia to Present at Upcoming Investor Conferences in March
    See more EXAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.12
    52 Week Low 4.14
    Average Volume 817,603
    200-Day Moving Average 6.00
    50-Day Moving Average 5.79
    20-Day Moving Average 4.93
    10-Day Moving Average 4.50
    Average True Range 0.34
    RSI (14) 31.97
    ADX 31.94
    +DI 12.61
    -DI 31.89
    Chandelier Exit (Long, 3 ATRs) 5.61
    Chandelier Exit (Short, 3 ATRs) 5.16
    Upper Bollinger Bands 6.01
    Lower Bollinger Band 3.84
    Percent B (%b) 0.19
    BandWidth 44.08
    MACD Line -0.46
    MACD Signal Line -0.41
    MACD Histogram -0.0424
    Fundamentals Value
    Market Cap 531 Million
    Num Shares 125 Million
    EPS -1.48
    Price-to-Earnings (P/E) Ratio -2.87
    Price-to-Sales 34.58
    Price-to-Book 1.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.56
    Resistance 3 (R3) 4.57 4.47 4.51
    Resistance 2 (R2) 4.47 4.40 4.47 4.49
    Resistance 1 (R1) 4.36 4.35 4.42 4.35 4.47
    Pivot Point 4.27 4.27 4.30 4.26 4.27
    Support 1 (S1) 4.16 4.19 4.21 4.15 4.03
    Support 2 (S2) 4.06 4.14 4.06 4.01
    Support 3 (S3) 3.95 4.06 3.99
    Support 4 (S4) 3.94